Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
AHA 25: MAPLE-HCM Responder Analysis
Author(s): Andrew Wang Added: 1 month ago
AHA Scientific Sessions 2025 – MAPLE-HCM responder analysis shows aficamten monotherapy led to greater treatment effect when compared to metoprolol monotherapy.Dr Andrew Wang (Duke University Medical Center, Durham, NC, US) presents a responder analysis from the MAPLE-HCM trial (NCT05767346), examining clinical responses to aficamten monotherapy versus metoprolol in patients with obstructive… View more

Heart Failure
ESC 25: EMORI-HCM: Electromagnetically Optimised Right Ventricular Pacing for oHCM
Author(s): Ahran D Arnold Added: 3 months ago
ESC Congress 2025 - EMORI-HCM finds that right ventricular pacing (iRVP) improves symptoms in obstructive hypertrophic cardiomyopathy (oHCM) patients.Dr Ahran Arnold (Imperial College London, UK) discusses findings from the EMORI-HCM study, exploring electro-mechanically optimised right ventricular pacing as a novel therapeutic approach for patients with oHCM.This interventional trial examined… View more

Electrophysiology & Arrhythmia

Heart Failure
Cardiomyopathy and Gender Disparities in South Asia
Author(s): Khalida Soomro , David Tak Wai Lui , Rungroj Krittayaphong , et al Added: 1 week ago

Demographic

Heart Failure
AHA 2023 CardioNerds Conference Scholars Late-Breaking Video Collection
Author(s): Mandeep Mehra , Christian Inchaustegui Added: 2 years ago
In 2023, we are excited to partner with @CardioNerds, a dynamic team dedicated to democratizing cardiovascular education. Experience a fresh perspective on the new data through an interview series featuring principal investigators and ambassadors from the CardioNerds family.These interviews are supported by an educational grant from Novo Nordisk Inc. This content is not intended for UK HCPs. View more

Heart Failure

Intervention
HFSA 25: The INTEGRA-D Trial
Author(s): Nir Uriel Added: 1 month ago
HFSA 25 - CCM-D was associated with successful defibrillation and symptom improvement in patients with HFrEF at 6 months in the INTEGRA-D Trial.Dr Nir Uriel (NewYork-Presbyterian, Columbia University Irving Medical Center, US) joins us to discuss findings from the Integra-D trial, evaluating a novel implantable device that provides both cardiac contractility modulation and defibrillation… View more

Heart Failure
Undiagnosed Sleep Apnoea Linked to Adverse Myocardial Remodelling in Hypertrophic Cardiomyopathy
Added: 2 months ago Source:  Radcliffe Cardiology
Sleep-disordered breathing (SDB), a condition mediated by intermittent hypoxaemia and autonomic dysregulation, is a well-established contributor to cardiovascular morbidity. A new prospective cohort study suggests that patients with hypertrophic cardiomyopathy (HCM) are particularly at risk, revealing a high prevalence of previously undiagnosed SDB in this population. The research links the… View more

Heart Failure

Imaging & Diagnostics
Background of Heart Failure
Author(s): Raluca Ibănescu , Diana-Alexandra Mîțu , Iacob-Daniel Goje , et al Added: 8 months ago

Imaging & Diagnostics

Heart Failure
AHA 24: The ENDEAVOR Trial
Author(s): Added: 1 year ago
AHA Conference 2024 - Primary safety and efficacy results from ENDEAVOR investigating the effect of myeloperoxidase inhibition with mitiperstat (AstraZeneca) on symptoms and exercise capacity in patients with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF).Dr Sanjiv Shah (Bluhm Cardiovascular Institute, Chicago, US) joins us onsite at AHA Conference to discuss the… View more

Heart Failure
Precision in Practice: Navigating Amyloidosis Diagnosis and Referral
Author(s): Margot K Davis , , , et al Added: 6 months ago
In this symposium, filmed at HFA 2025 (Belgrade, RS), moderator Dr Margot Davis (Vancouver, CA) is joined by Prof Fabian Knebel (Berlin, DE), Dr AleksandarAleksandrov (Berlin, DE) and Prof Olivier Lairez (Toulouse, FR) to unpack a recent, real-life patient referral. The faculty explore the challenges faced during the referral process and then evaluate the practical steps for making a confident… View more

Heart Failure
ESC 23 Late-Breaker Discussion: The STEP HFpEF Trial
Author(s): Harriette Van Spall , Mikhail Kosiborod Added: 2 years ago
ESC 2023 – Late-Breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by Dr Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, US) to discuss the findings from the STEP HFpEF trial (NCT04788511). Around half of patients with heart failure have heart failure with preserved ejection fraction (HFpEF), and most patients with HFpEF are overweight or obese. Patients with… View more

Heart Failure

Prevention & Chronic Conditions